NASDAQ · USD
enGene Therapeutics Inc. (ENGNW) Stock Analysis
enGene Therapeutics Inc. (ENGNW) is a stock listed on NASDAQ and quoted in US Dollar.
ENGNW
$0.23
+$0.01 (+4.55%)
Sep 4, 2026 · Market close
This is a derivative instrument — a warrant on enGene Therapeutics Inc. (ENGN) common stock.
Issuer fundamentals are shown on the issuer page, not here.
View ENGN →Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ENGNW Key Statistics
As of Sep 4, 2026Trading
- Open
- $2.10
- Previous Close
- $0.22
- Day's Range
- 0.22–0.23
- 52-Week Range
- 0.22–0.23
- Volume
- 1.21K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- −0.28
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
ENGNW Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −92.33% |
| 2025 (partial year) | +20.48% |
As of September 4, 2026.
Recent News
enGene to Participate in Upcoming Investor Conferences
YahooenGene Eyes 2027 Approval as Detalimogene Targets Expanding Bladder Cancer Market
YahooenGene Therapeutics Inc. (ENGN) Discusses Market Insights and Clinical Development in Non-Muscle Invasive Bladder Cancer Transcript
SeekingAlphaenGene Therapeutics Inc. (ENGN) Discusses Market Insights and Clinical Development in Non-Muscle Invasive Bladder Cancer - Slideshow
SeekingAlpha
News provided by third-party sources. Not financial advice.